期刊文献+

广西地区乙肝病毒/黄曲霉毒素双暴露因素下肝细胞癌染色体遗传学改变的初步研究 被引量:4

Chromosome genetic changes in hepatocellular carcinoma with double exposure to hepatitis B virus/aflatoxin B1 : A preliminary study from Guangxi
原文传递
导出
摘要 目的 探讨广西地区人群乙肝病毒/黄曲霉毒素(HBV/AFBl)双暴露相关性肝细胞癌(HCC)染色体遗传学改变的特点。方法 32例HCC的癌组织,运用微阵列比较基因组杂交技术(ArrayCGH)检测其22对染色体的变化。结果 (1)32例HCC中,大部分的染色体拷贝数都有不同程度的变化。发生扩增的区段有1q、7q、8q,其中1q、8q为高频扩增区段。发生缺失区段有1p、4q、8p、9p、13q、14q、16p、16q、17p、18q、19p、Y,其中1p、4q、8p、16q、17p、19p为高频缺失区段;(2)同时,还存在着若干DNA拷贝数扩增或缺失的小区段。缺失显著的小区段有:2p25.1-p25.2、3q22.3-q23、7p14.1-p14.3。扩增显著的小区段有:9p13.2-9p21;(3)聚类分析发现:13q缺失发生率在HBsAg(+)/AFBl(+)、HBsAg(+)/AFBl(-)、HBsAg(-)/AFBl(+)、HBsAg(-)/AFBl(-)4个亚组中呈依次递减(霄-6.452,P〈0.05)。4p在HBsAg(+)/AFBl(-)组中以扩增为主,而在HBsAg(-)/AFBl(+)组与HBsAg(-)/AFBl(-)组则以缺失为主。19q在HBsAg(+)/AFBl(+)组中以扩增为主,在HBsAg(-)/AFBl(+)组与HBsAg(-)/AFBl(-)组中以缺失为主。结论 广西地区肝癌染色体遗传学改变具有多样性,其中19p、2p25.1—25.2、3q22.3-q23的缺失及9p13.2-9p21的扩增可能为该地区肝癌特有的遗传学特征之-。13q的缺失可能与该地区乙肝病毒/黄曲霉毒素双因素的协同作用有关。 Objective To study the chromosome genetic changes in hepatocellular carcinoma (HCC) with double exposure to hepatitis B virus/aflatoxin B1 (HBV/AFBI) in Guangxi. Method Differences in genomic alterations in 32 patients with HCC were analyzed using comparative genomic hybridization(CGH). Results (1) The majority of chromosome copy number in the 32 HCC samples had varying degrees of change. The amplification of chromosome regions were lq, 7q, 8q, with the high frequency regions being lq, 8q. The deletion of chromosome regions were lp, 4q, 8p, 9p, 13q, 14q, 16p, 16q, 17p, 18q, 19p, Y, with the high frequency regions being lp, 4q, 8p, 16q, 17p, 19p; (2) There were also some high copy number amplification or deletion of small regions, such as 2p25.1-p25.2, 3q22.3-q23, 7p14. 1-p14. 3, and 9p13. 2-9p21; (3) Hierarchical clustering analysis showed that the rate of deletion of chromosome 13q decreased progressively in the following 4 groups :- HBsAg(+)/AFBI(+), HBsAg(+)/AFBI(-), HBsAg(-)/AFBI(+), and HBsAg(-)/AFB1 (-) (x2 = 6. 452,P〈0. 05). 4p was found mainly to be amplified in the HBsAg ( + )/AFB1 ( - ) group, hut it was mainly deleted in the HBsAg(- )/AFBI(+ ), and HBsAg(- )/AFB1 (-) groups. 19q was found mainly to be amplified in the H BsAg(+ )/AFBI(-) group, but it was mainly deleted in the HBsAg(-)/AFBI(+), and HBsAg(-)/AFBI(-) groups. Conclusion The chromosome genetic changes of HCC in Guangxi showed multiplicity. The deletion of chromosome 19p, 2p25. 1- 25.2, 8q22.3-q23, 7p14.1-p14.3 and amplification of chromosome 9p13.2-9p21 are probably uniGue genetic characteristics of HCC in this region. The combined effects of Hepatitis B virus and aflatoxin B1 may contribute to deletion of chromosome 13q of HCC in Guangxi.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2012年第1期9-14,共6页 Chinese Journal of Hepatobiliary Surgery
基金 基金项目:国家自然科学基金资助项目(NO.30960021) 广西科学基金项目基金资助项目(桂科基NO.0640101)
关键词 广西地区 肝细胞癌 乙肝病毒 黄曲霉毒素 染色体 Array CGH Guangxi area Hepatocellular carcinoma Hepatitis B virus Aflatoxin B1 Chromosome Array CGH
  • 相关文献

参考文献16

  • 1Wong N,Lai P,Lee SW,et al.Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis:relationship to disease stage,tumor size,and cirrhosis[J].Am J Patbology,1999,154,37-43.
  • 2Wong N,Lai P,Lee SW,et al.Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma[J]. Am J Patbology,2001,154:445-471.
  • 3Niketeghad F,Decker HJ,Caselmann WH,et al.Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis[J]. British Journal of Cancer,2001,85:697-704.
  • 4Hashimoto K,Mori N,Tamesa T,et al.Analysis of DNA copy number aberrations in hepatitis C virus-associated hepatocellular carcinomas by conventional CGH and array CGH[J].Modern Pathology,2004,17:617-622.
  • 5Park SJ,Jeong SY,Kim HJ,et al.Y chromosome loss and other genomic alterations in hepatocellular carcinoma cell lines analyzed by CGH and CGH array[J].Cancer genetics and cytogenetics,2006,166:56-64.
  • 6Patil MA,Gütgemann I,Zhang I,et al.Array-based compar ative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma[J].Carcinogenesis,2005,26:2050-2057.
  • 7Taniguchi K,Yamada T,Sasaki Y,et al.Genetic and epigenetic characteristics of human multiple hepatocellular carcinoma[J].BMC Cancer,2010,10:530.
  • 8武金才,孙冰生,刘道永,李国才,史炯,任宁,叶青海,钦伦秀.比较基因组杂交芯片技术对肝癌组织中骨桥蛋白不同表达肿瘤细胞基因组的研究[J].中华肝胆外科杂志,2008,14(12):854-857. 被引量:6
  • 9Guengerich FP,Johnson WW,Shimada T,et al.Activation and detoxication of aflatoxin B1[J].Mutat Res,1998,402(1-2):121-128.
  • 10Zhang YJ,Rossner P,Jr,Chen Y,et al.Aflatoxin B1 and polycyclic aromatic hydrocarbon adducts,p53 mutations and p16 methylation in liver tissue and plasma of hepatocellular carcinoma patients[J].Int J Cancer,2006,119:985-991.

二级参考文献11

  • 1Ye QH, Qin LX, Forgues M, et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med, 2003, 9: 416-423.
  • 2Zhang H, Ye QH, Ren N, et al. The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma. J Cancer Res Clin Oncol, 2006, 132:709-717.
  • 3Chen H, Ke Y, Oates AJ, et al. Isolation of and effector for metastasis-inducing DNAs from a human metastatic carcinoma cell line. Oneogene, 1997, 14: 1581-1588.
  • 4Gotoh M, Sakamoto M, Kanetaka K, et al. Overexpression of osteopontin in hepatocellular carcinoma. Pathol Int, 2002, 52: 19-24.
  • 5Shipitsin M, Campbell L, Argani P, et al. Molecular definition of breast tumor heterogeneity. Cancer Cell, 2007, 11: 259-273.
  • 6Wang XH, Fan MW, Chen XM, et al. Intratumor genomic heterogeneity correlates with histological grade of advanced oral squamous cell carcinoma. Oral Oncology, 2006, 42: 740- 744.
  • 7Huang J, Sheng HH, Shen T, et al. Correlation between genomic DNA copy number alterations and transcriptional expression in hepatitis B virus associated hepatocellular carcinoma. FEBS Letters, 2006, 580:3571-3581.
  • 8Liang F, Liang J, Wang WQ, et al. PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation. J Biol Chem, 2007, 282:5413-5419.
  • 9Retz M, Lehmann J, Szysnik C, et al. Detection of occult tumor cells in lymph nodes from bladder cancer patients by MUC7 nested RT PCR. Eur Urol, 2004, 45:314-319.
  • 10Herath NI, Spanevello MD, Sabesan S, et al. Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival. BMC Cancer, 2006, 6:144.

共引文献5

同被引文献50

  • 1蒋素贞,杨紫伟,李韦杰,李晓君,陈香梅,鲁凤民.原发性肝细胞癌中HBV DNA整合位点分析[J].中国医学前沿杂志(电子版),2011,3(1):56-60. 被引量:3
  • 2张豪,孙桂菊,屠红,金晏,许丽,钱耕荪.用cDNA微阵列技术研究HBV X基因与AFB_1对HBVx转基因小鼠药物代谢酶基因表达谱的影响[J].肿瘤,2005,25(2):128-131. 被引量:6
  • 3Wong N,Lai P,Lee SW,et al.Hypomethylation of chromosome I hel-erochromatin DNA correlates with q-Arm copy gain in human hepatocellular carcinoma [ J ].Am J Patbology, 2001,154 ( 7 ) : 445- 471.
  • 4Hashimoto K, Mori N ,Tamesa T,et al.Analysis of DNA copy number aberrations in hepatitis C virus-associated hepatocellular carcinomas by conventional CGH and array CGH[ J ].Mmtern Pathology, 2004.17 (6): 617-622.
  • 5Park SJ,Jeong SY.Chromosome loss and other genomic alterations in hepatocellular carcinoma cell lines analyzed by CGH and CGH array [J ].Cancer Genetics and Cytogenetics, 2006,166( 11 ) : 56-64.
  • 6Patil MA,Gutgemann I,Zhang I,et al.Array-based comparative ge- nomic hybridization reveals recurrent chromosomal aberrations and Jabl as a potential target for 8q gain in hepatncellular carcinoma[J]. Carcinogenesis, 2005, 26(6): 2050-2057.
  • 7Taniguchi K, Yamada T, Sasaki Y, et al.Genetic and epigenetic char- acteristics of human multiple hepatocellular carcinoma[J].BMC Can- eer,2010,10(6):530-535.
  • 8Rajagopal N, Clifford J,Erik NK.et al.Molecular mechanisms of he- patocellular carcinoma[ J ].Hepatology, 2008,48 (3) : 2047-2063.
  • 9Guengerich FP,Johnson WW,Shimada T,et al.Activation and detox- ication of aflatoxin B,[J]. Murat Res, 1998, 402( 1-2): 121-128.
  • 10Zhang YJ,Rossner P, Chen Y,et al.Aflatoxin B: and polycyclic aro-matic hydrocarbon adducts,p53 mutations and p16 methylation in liv- er tissue and plasma of hepatoeellular carcinoma patients [ J ].Int J Cancer, 2006, 119(5) :985-991.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部